Prospects for Using Expression Patterns of Paramyxovirus Receptors as Biomarkers for Oncolytic Virotherapy
The effectiveness of oncolytic virotherapy in cancer treatment depends on several factors, including successful virus delivery to the tumor, ability of the virus to enter the target malignant cell, virus replication, and the release of progeny virions from infected cells. The multi-stage process is...
Main Authors: | Olga V. Matveeva, Svetlana A. Shabalina |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/12/3659 |
Similar Items
-
Measles to the Rescue: A Review of Oncolytic Measles Virus
by: Sarah Aref, et al.
Published: (2016-10-01) -
Bovine pestivirus is a new alternative virus for multiple myeloma oncolytic virotherapy
by: Valentina Marchica, et al.
Published: (2020-07-01) -
Oncolytic virotherapy
by: Daniel Cervantes-García;, et al.
Published: (2008-01-01) -
From Benchtop to Bedside: A Review of Oncolytic Virotherapy
by: Audrey H. Choi, et al.
Published: (2016-08-01) -
Starvation-Induced Differential Virotherapy Using an Oncolytic Measles Vaccine Virus
by: Gabriel Scheubeck, et al.
Published: (2019-07-01)